Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-057627
Filing Date
2008-03-17
Accepted
2008-03-14 17:38:02
Documents
6
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1118607
2 CONSENT OF BDO SEIDMAN, LLP dex231.htm EX-23.1 3097
3 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF RICHARD B. HOLLIS dex311.htm EX-31.1 10123
4 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF ROBERT W. WEBER dex312.htm EX-31.2 10276
5 SECTION 1350 CERTIFICATIONS OF RICHARD B. HOLLIS AND ROBERT W. WEBER dex321.htm EX-32.1 6232
6 GRAPHIC g15313g45l47.jpg GRAPHIC 50462
  Complete submission text file 0001193125-08-057627.txt   1219552
Mailing Address 4435 EASTGATE MALL SUITE 400 SAN DIEGO CA 92121
Business Address 4435 EASTGATE MALL SUITE 400 SAN DIEGO CA 92121 858-587-9333
HOLLIS EDEN PHARMACEUTICALS INC /DE/ (Filer) CIK: 0000899394 (see all company filings)

EIN.: 133697002 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24672 | Film No.: 08690592
SIC: 2834 Pharmaceutical Preparations